Mylan, Lupin Announce Positive CHMP Opinion for Nepexto Medical Dialogues Bureau29 March 2020 1:32 PM ISTHertfordshire, Pittsburgh, and Mumbai: Mylan N.V. and Lupin Limited (Lupin) has announced that the European Medicines Agency's Committee for Medicinal...
NPPA directs 3 pharma cos to maintain stock of atleast 2.2 crore tablets of FDC Lopinavir and Ritoavir Medical Dialogues Bureau29 March 2020 1:19 PM ISTNew Delhi: The National Pharmaceuticals Pricing Authority (NPPA), Department of Pharmaceuticals directed 3 major manufacturers of the HIV Combo...
Mylan, Pfizer Upjohn merger gets delayed in light on coronavirus Medical Dialogues Bureau28 March 2020 1:30 PM ISTHertfordshire & Pittsburgh: Mylan N.V. and Pfizer Inc. today announced that due to the unprecedented circumstances surrounding the COVID-19...
Biocon, Mylan win patent rights for Insulin Glargine Device against Sanofi Medical Dialogues Bureau12 March 2020 11:29 AM ISTInsulin Glargine is a long-acting insulin used to treat adults with Type 2 diabetes and adults and paediatric patients with Type 1 diabetes for the...
USFDA Accepts Biocon, Mylan's application for review of Proposed Biosimilar of Bevacizumab Medical Dialogues Bureau10 March 2020 1:15 PM ISTBiocon Ltd. and Mylan N.V. announced that the U.S. Food and Drug Administration (FDA) has accepted Mylan's Biologics License Application (BLA)...
Mylan warns of possible drug shortages, financial hit due to coronavirus Medical Dialogues Bureau29 Feb 2020 9:30 AM ISTAlthough heavily reliant on China, the company said it was better positioned against the impact of the outbreak compared to its peers due to its...
Sanjeev Narula CFO Pfizer Upjohn appointed as incoming CFO of Viatris Medical Dialogues Bureau28 Feb 2020 1:45 PM ISTViatris is the new company that will result from the planned combination of Mylan and Upjohn
Beximco Pharma announces Commercial Agreement with Mylan in Bangladesh Medical Dialogues Bureau25 Feb 2020 4:28 PM ISTBeximco Pharmaceuticals Limited, manufacturer of generic pharmaceutical products and active pharmaceutical ingredients, has announced the signing of a...
Sanofi asks US court to halt diabetes drug patent fight with Mylan Medical Dialogues Bureau12 Feb 2020 10:30 AM IST In a stay application filed on Friday, Sanofi said a recent U.S. Court of Appeals for the Federal Circuit decision upholding the invalidation of two...
NPPA fixes price of 21 formulations including diabetes drugs, others; Details Farhat Nasim11 Feb 2020 12:17 PM ISTNew Delhi: Through a recent notice, the National Pharmaceutical Pricing Authority (NPPA), Ministry of Chemicals and Fertilizers, Government of India...
Emcure plea to direct NPPA to review HIV drugs price junked by DoP Farhat Nasim3 Feb 2020 1:41 PM ISTNew Delhi: In a setback to drugmaker Emcure Pharmaceuticals, the Department of Pharmaceuticals (DoP) has rejected the company's petition seeking to...
FIRST: Mylan, Micro Labs get USFDA nod for generic version of blood thinner Eliquis Medical Dialogues Bureau24 Dec 2019 9:45 AM ISTSales of Eliquis, which Bristol-Myers co-developed with Pfizer, rose 22% to $1.93 billion and made up about 30% of the Bristol-Myers' total revenues...
